Market Trends, Business Strategies, Competitive Intelligence, Clinical Trials, and Patent Trends Driving Growth from 2024 to 2029"Boston, July 10, 2025 (GLOBE NEWSWIRE) -- According to the latest ...

Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and ...

This study reveals that neutrophil extracellular traps (NETs) drive macrophage-derived chemokine production (CXCL9/10/11) to promote CD8+ T cell ...

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated ...

The chemical is bis (2,2,6,6-tetramethyl-4-piperidyl) sebacate, also called BTMPS, which is in a group of chemicals called hindered amine light stabilizers. BTMPS is usually added to plastics, ...

University of Osaka researchers used genome editing to program mouse liver cells to produce exenatide, a weight-loss drug.

AbbVie (ABBV) and IGI Therapeutics SA have entered into an exclusive licensing agreement for the latter’s lead ...

A new study has found that psilocin—a compound produced in the body after consuming psilocybin, the active ingredient in psychedelic mushrooms—extended the lifespan of human skin and lung cells in the ...

Psilocybin, the active compound derived from psychedelic mushrooms, significantly delayed cellular aging and extended ...

The mobile units address critical access barriers by bringing FDA-approved targeted therapy directly to local clinics and communities through equipped RVs.

(NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Commission has approved TEVIMBRA ® (tislelizumab), in combination with gemcitabine and cisplatin, ...

You eat well, you move your body, and you try to stay on top of your health—but the stubborn fat, especially around your ...